Hester Biosciences Ltd.
BSE: 524669 | Sector: Health care |
NSE: HESTERBIO | ISIN Code: INE782E01017 |
BSE 00:00 | 16 Apr | 2349.45 |
336.45 (16.71%) |
OPEN
2051.00 |
HIGH
2401.45 |
LOW
2039.65 |
NSE 00:00 | 16 Apr | 2343.85 |
329.90 (16.38%) |
OPEN
2069.00 |
HIGH
2399.90 |
LOW
2013.95 |
OPEN | 2051.00 |
PREVIOUS CLOSE | 2013.00 |
VOLUME | 13649 |
52-Week high | 2401.45 |
52-Week low | 980.00 |
P/E | 55.45 |
Mkt Cap.(Rs cr) | 1,999 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Hester Biosciences Ltd. (HESTERBIO) - Net Profit
Net Profit
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
Sun Pharma.Inds. | 646.05 | 13.10 | 2.07 | 3211.14 |
Dr Reddy's Labs | 4893.00 | 50.55 | 1.04 | 2937.70 |
Cipla | 938.70 | 24.50 | 2.68 | 2318.17 |
Aurobindo Pharma | 953.00 | 38.35 | 4.19 | 1872.74 |
Cadila Health. | 527.00 | 23.00 | 4.56 | 1412.90 |
Divi's Lab. | 3823.70 | 40.75 | 1.08 | 1372.71 |
Glenmark Pharma. | 571.90 | 35.10 | 6.54 | 1354.55 |
Alkem Lab | 2790.45 | 43.00 | 1.57 | 1264.42 |
Alembic Pharma | 1000.60 | 28.60 | 2.94 | 969.40 |
Torrent Pharma. | 2619.15 | 52.85 | 2.06 | 938.51 |
Gland Pharma | 2629.10 | 145.80 | 5.87 | 772.86 |
Lupin | 1055.85 | 6.10 | 0.58 | 727.55 |
Ipca Labs. | 2143.20 | 41.50 | 1.97 | 652.46 |
Abbott India | 14962.95 | 21.30 | 0.14 | 592.93 |
Fortis Health. | 203.40 | -2.75 | -1.33 | 513.33 |
Pfizer | 5219.30 | 87.65 | 1.71 | 509.13 |
Sanofi India | 8050.70 | 11.55 | 0.14 | 477.60 |
Natco Pharma | 921.85 | 10.25 | 1.12 | 474.50 |
Apollo Hospitals | 3060.20 | 69.40 | 2.32 | 470.30 |
Granules India | 327.15 | 9.80 | 3.09 | 444.07 |
Quick Links for Hester Biosciences:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices